An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study

NCT01588184 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Bevacizumab

Sponsor

Hoffmann-La Roche